1. Bovolenta, T.M., Silva, S.M.C.A., Saba, R.A., Borges, V., Ferraz, H.B., Felicio, A.C.: Average annual cost of Parkinson’s disease in São Paulo, Brazil, with a focus on disease-related motor symptoms. Clin. Interv. Aging 12, 2095–2108 (2017)
2. Bovolenta, TM., Silva, S.M.C.A., Saba, R.A., Borges, V., Ferraz, H,B., Felicio, A.C.: Systematic review and critical analysis of cost studies associated with Parkinson’s Disease. Hindawi Parkinson’s Disease, 1–11 (2017)
3. Brasil. Ministério da Saúde.: Avaliação econômica em saúde: desafios para gestão no Sistema Único de Saúde. Ministério da Saúde, Brasília (2008)
4. Cubo, E., Alvarez, E., Morant, C., Cuesta, J.P., Martín, P.M., Génova, R., Freire, J.M.: Burden of disease related to Parkinson’s Disease in Spain in the Year 2000. Mov. Disord. 20(11), 1481–1487 (2005)
5. Daneault, J.F., Carignan, B., Sadikot, A.F., Panisset, M., Duval, C.: Drug-induced dyskinesia in Parkinson’s disease: should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? BMC Med. 11(73), 1–18 (2013)